U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Partial retinal vein occlusion

MedGen UID:
78753
•Concept ID:
C0271080
•
Disease or Syndrome
Synonyms: Partial occlusion of retinal vein; partial occlusion of retinal vein; Partial Retinal Vein Occlusion; partial retinal vein occlusion
SNOMED CT: Partial occlusion of retinal vein (65593009)
 
Monarch Initiative: MONDO:0002088

Professional guidelines

PubMed

Paracentral Acute Middle Maculopathy and the Ischemic Cascade: Toward Interventional Management.
Zhao PY, Johnson MW, McDonald HR, Sarraf D
Am J Ophthalmol 2022 Feb;234:15-19. Epub 2021 Jul 31 doi: 10.1016/j.ajo.2021.07.030. PMID: 34343488
Central retinal vein occlusion: modifying current treatment protocols.
Ashraf M, Souka AA, Singh RP
Eye (Lond) 2016 Apr;30(4):505-14. Epub 2016 Feb 12 doi: 10.1038/eye.2016.10. PMID: 26869163Free PMC Article
Treatment of chronic macular edema with acetazolamide.
Cox SN, Hay E, Bird AC
Arch Ophthalmol 1988 Sep;106(9):1190-5. doi: 10.1001/archopht.1988.01060140350030. PMID: 3415543

Recent clinical studies

Etiology

Recombinant Plasminogen Activator Modified Nanoparticles for Targeting Thrombolysis in Branch Retinal Vein Occlusion.
Zhang H, Han S, Zhang L, Guo Y, Li Y
Cell Mol Biol (Noisy-le-grand) 2022 Mar 31;68(3):201-212. doi: 10.14715/cmb/2022.68.3.23. PMID: 35988180
Hemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk Factors.
Ashkenazy N, Patel NA, Sridhar J, Yannuzzi NA, Belin PJ, Kaplan R, Kothari N, Benitez Bajandas GA, Kohly RP, Roizenblatt R, Pinhas A, Mundae R, Rosen RB, Ryan EH Jr, Chiang A, Chang LK, Khurana RN, Finn AP
Ophthalmol Retina 2022 Jun;6(6):520-530. Epub 2022 Mar 10 doi: 10.1016/j.oret.2022.02.004. PMID: 35278727Free PMC Article
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.
Li Y, Hall NE, Pershing S, Hyman L, Haller JA, Lee AY, Lee CS, Chiang M, Lum F, Miller JW, Lorch A, Elze T
Ophthalmol Retina 2022 Feb;6(2):161-171. Epub 2021 May 12 doi: 10.1016/j.oret.2021.05.004. PMID: 33991710Free PMC Article
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal O, Mimouni M, Rabina G, Yavnieli R, Nemet AY
Int Ophthalmol 2021 Feb;41(2):533-540. Epub 2020 Oct 22 doi: 10.1007/s10792-020-01604-0. PMID: 33094440
Metabolomic analysis of the aqueous humor from patients with central retinal vein occlusion using UHPLC-MS/MS.
Wei P, He M, Teng H, Han G
J Pharm Biomed Anal 2020 Sep 5;188:113448. Epub 2020 Jun 25 doi: 10.1016/j.jpba.2020.113448. PMID: 32622112

Diagnosis

Combined central retinal vein and cilioretinal artery occlusion in a 25-year-old woman.
Sedlak L, Świerczyńska M, Pojda-Wilczek D
Rom J Ophthalmol 2022 Apr-Jun;66(2):178-184. doi: 10.22336/rjo.2022.35. PMID: 35935085Free PMC Article
Hemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk Factors.
Ashkenazy N, Patel NA, Sridhar J, Yannuzzi NA, Belin PJ, Kaplan R, Kothari N, Benitez Bajandas GA, Kohly RP, Roizenblatt R, Pinhas A, Mundae R, Rosen RB, Ryan EH Jr, Chiang A, Chang LK, Khurana RN, Finn AP
Ophthalmol Retina 2022 Jun;6(6):520-530. Epub 2022 Mar 10 doi: 10.1016/j.oret.2022.02.004. PMID: 35278727Free PMC Article
Paracentral Acute Middle Maculopathy and the Ischemic Cascade: Toward Interventional Management.
Zhao PY, Johnson MW, McDonald HR, Sarraf D
Am J Ophthalmol 2022 Feb;234:15-19. Epub 2021 Jul 31 doi: 10.1016/j.ajo.2021.07.030. PMID: 34343488
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.
Li Y, Hall NE, Pershing S, Hyman L, Haller JA, Lee AY, Lee CS, Chiang M, Lum F, Miller JW, Lorch A, Elze T
Ophthalmol Retina 2022 Feb;6(2):161-171. Epub 2021 May 12 doi: 10.1016/j.oret.2021.05.004. PMID: 33991710Free PMC Article
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal O, Mimouni M, Rabina G, Yavnieli R, Nemet AY
Int Ophthalmol 2021 Feb;41(2):533-540. Epub 2020 Oct 22 doi: 10.1007/s10792-020-01604-0. PMID: 33094440

Therapy

Recombinant Plasminogen Activator Modified Nanoparticles for Targeting Thrombolysis in Branch Retinal Vein Occlusion.
Zhang H, Han S, Zhang L, Guo Y, Li Y
Cell Mol Biol (Noisy-le-grand) 2022 Mar 31;68(3):201-212. doi: 10.14715/cmb/2022.68.3.23. PMID: 35988180
Paracentral Acute Middle Maculopathy and the Ischemic Cascade: Toward Interventional Management.
Zhao PY, Johnson MW, McDonald HR, Sarraf D
Am J Ophthalmol 2022 Feb;234:15-19. Epub 2021 Jul 31 doi: 10.1016/j.ajo.2021.07.030. PMID: 34343488
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal O, Mimouni M, Rabina G, Yavnieli R, Nemet AY
Int Ophthalmol 2021 Feb;41(2):533-540. Epub 2020 Oct 22 doi: 10.1007/s10792-020-01604-0. PMID: 33094440
Central retinal vein occlusion: modifying current treatment protocols.
Ashraf M, Souka AA, Singh RP
Eye (Lond) 2016 Apr;30(4):505-14. Epub 2016 Feb 12 doi: 10.1038/eye.2016.10. PMID: 26869163Free PMC Article
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W
Thromb Haemost 2010 Feb;103(2):271-6. Epub 2009 Dec 1 doi: 10.1160/TH09-09-0626. PMID: 20126837

Prognosis

Hemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk Factors.
Ashkenazy N, Patel NA, Sridhar J, Yannuzzi NA, Belin PJ, Kaplan R, Kothari N, Benitez Bajandas GA, Kohly RP, Roizenblatt R, Pinhas A, Mundae R, Rosen RB, Ryan EH Jr, Chiang A, Chang LK, Khurana RN, Finn AP
Ophthalmol Retina 2022 Jun;6(6):520-530. Epub 2022 Mar 10 doi: 10.1016/j.oret.2022.02.004. PMID: 35278727Free PMC Article
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.
Li Y, Hall NE, Pershing S, Hyman L, Haller JA, Lee AY, Lee CS, Chiang M, Lum F, Miller JW, Lorch A, Elze T
Ophthalmol Retina 2022 Feb;6(2):161-171. Epub 2021 May 12 doi: 10.1016/j.oret.2021.05.004. PMID: 33991710Free PMC Article
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal O, Mimouni M, Rabina G, Yavnieli R, Nemet AY
Int Ophthalmol 2021 Feb;41(2):533-540. Epub 2020 Oct 22 doi: 10.1007/s10792-020-01604-0. PMID: 33094440
Metabolomic analysis of the aqueous humor from patients with central retinal vein occlusion using UHPLC-MS/MS.
Wei P, He M, Teng H, Han G
J Pharm Biomed Anal 2020 Sep 5;188:113448. Epub 2020 Jun 25 doi: 10.1016/j.jpba.2020.113448. PMID: 32622112
Central retinal vein occlusion: modifying current treatment protocols.
Ashraf M, Souka AA, Singh RP
Eye (Lond) 2016 Apr;30(4):505-14. Epub 2016 Feb 12 doi: 10.1038/eye.2016.10. PMID: 26869163Free PMC Article

Clinical prediction guides

Recombinant Plasminogen Activator Modified Nanoparticles for Targeting Thrombolysis in Branch Retinal Vein Occlusion.
Zhang H, Han S, Zhang L, Guo Y, Li Y
Cell Mol Biol (Noisy-le-grand) 2022 Mar 31;68(3):201-212. doi: 10.14715/cmb/2022.68.3.23. PMID: 35988180
Combined central retinal vein and cilioretinal artery occlusion in a 25-year-old woman.
Sedlak L, Świerczyńska M, Pojda-Wilczek D
Rom J Ophthalmol 2022 Apr-Jun;66(2):178-184. doi: 10.22336/rjo.2022.35. PMID: 35935085Free PMC Article
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal O, Mimouni M, Rabina G, Yavnieli R, Nemet AY
Int Ophthalmol 2021 Feb;41(2):533-540. Epub 2020 Oct 22 doi: 10.1007/s10792-020-01604-0. PMID: 33094440
Central retinal vein occlusion: modifying current treatment protocols.
Ashraf M, Souka AA, Singh RP
Eye (Lond) 2016 Apr;30(4):505-14. Epub 2016 Feb 12 doi: 10.1038/eye.2016.10. PMID: 26869163Free PMC Article
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W
Thromb Haemost 2010 Feb;103(2):271-6. Epub 2009 Dec 1 doi: 10.1160/TH09-09-0626. PMID: 20126837

Recent systematic reviews

Emerging applications of bioinformatics and artificial intelligence in the analysis of biofluid markers involved in retinal occlusive diseases: a systematic review.
Pur DR, Krance S, Pucchio A, Bassi A, Miranda RN, Felfeli T
Graefes Arch Clin Exp Ophthalmol 2023 Feb;261(2):317-336. Epub 2022 Aug 4 doi: 10.1007/s00417-022-05769-5. PMID: 35925451
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W
Thromb Haemost 2010 Feb;103(2):271-6. Epub 2009 Dec 1 doi: 10.1160/TH09-09-0626. PMID: 20126837

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...